The Food and Drug Administration (FDA) carried out a bioresearch monitoring inspection of Michael J. Thirman, M.D., located in Chicago, on April 9, 2024, according to data posted on the FDA's website.

The FDA's final report concluded that Michael J. Thirman, M.D. was not required to take any corrective actions regarding the management of its operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medica

See Full Page